The natural history of Niemann-Pick disease type C in the UK

被引:104
作者
Imrie, J. [1 ]
Dasgupta, S.
Besley, G. T. N.
Harris, C.
Heptinstall, L.
Knight, S.
Vanier, M. T.
Fensom, A. H.
Ward, C.
Jacklin, E.
Whitehouse, C.
Wraith, J. E.
机构
[1] Royal Manchester Childrens Hosp, Willink Biochem Genet Unit, Manchester M27 1HA, Lancs, England
[2] Ctr Hosp Lyon Sud, Lab Fdn Gillet Merieux, F-69310 Pierre Benite, France
[3] Fac Med Lyon Sud, Inserm U189, Oullins, France
[4] Guys Hosp, Genet Ctr, London SE1 9RT, England
关键词
D O I
10.1007/s10545-006-0384-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Niemann-Pick disease type C (NPC) is an autosomal recessive, neurovisceral lipid storage disorder. Mutations in two genes (NPC1 and NPC2) produce indistinguishable clinical phenotypes by biochemical mechanisms that have not yet been entirely clarified. The wide spectrum of clinical presentations of NPC includes hepatic and pulmonary disease as well as a range of neuropsychiatric disorders. Late-onset disease has been increasingly recognized as the biochemical diagnosis of NPC has been more widely applied in adult neurology clinics. The clinical presentation and follow-up of 94 patients with NPC is described, 58 of whom were still alive at the time this report was prepared. The age at diagnosis ranged from the prenatal period (with hydrops fetalis) up to 51 years. This review of NPC patients in the UK confirms the phenotypic variability of this inherited lipid storage disorder reported elsewhere. Although a non-neuronopathic variant has been described, most patients in this series who survived childhood inevitably suffered neurological and in some cases neuropsychiatric deterioration. While symptomatic treatment, such as anticholinergic and antiepileptic drugs, can alleviate some aspects of the disease, there is a clear need to develop a specific treatment for this progressively debilitating neurodegenerative disorder.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 23 条
[1]  
BUTLER JD, 1992, J BIOL CHEM, V267, P23797
[2]   Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis [J].
Carstea, ED ;
Morris, JA ;
Coleman, KG ;
Loftus, SK ;
Zhang, D ;
Cummings, C ;
Gu, J ;
Rosenfeld, MA ;
Pavan, WJ ;
Krizman, DB ;
Nagle, J ;
Polymeropoulos, MH ;
Sturley, SL ;
Ioannou, YA ;
Higgins, ME ;
Comly, M ;
Cooney, A ;
Brown, A ;
Kaneski, CR ;
BlanchetteMackie, EJ ;
Dwyer, NK ;
Neufeld, EB ;
Chang, TY ;
Liscum, L ;
Strauss, JF ;
Ohno, K ;
Zeigler, M ;
Carmi, R ;
Sokol, J ;
Markie, D ;
ONeill, RR ;
vanDiggelen, OP ;
Elleder, M ;
Patterson, MC ;
Brady, RO ;
Vanier, MT ;
Pentchev, PG ;
Tagle, DA .
SCIENCE, 1997, 277 (5323) :228-231
[3]   The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease:: A position statement [J].
Cox, TM ;
Aerts, JMFG ;
Andria, G ;
Beck, M ;
Belmatoug, N ;
Bembi, B ;
Chertkoff, R ;
Vom Dahl, S ;
Elstein, D ;
Erikson, A ;
Giralt, M ;
Heitner, R ;
Hollak, C ;
Hrebicek, M ;
Lewis, S ;
Mehta, A ;
Pastores, GM ;
Rolfs, A ;
Miranda, MCS ;
Zimran, A .
JOURNAL OF INHERITED METABOLIC DISEASE, 2003, 26 (06) :513-526
[4]   Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease [J].
Elstein, D ;
Hollak, C ;
Aerts, JMFG ;
van Weely, S ;
Maas, M ;
Cox, TM ;
Lachmann, RH ;
Hrebicek, M ;
Platt, FM ;
Butters, TD ;
Dwek, RA ;
Zimran, A .
JOURNAL OF INHERITED METABOLIC DISEASE, 2004, 27 (06) :757-766
[5]   Pharmacological and genetic modifications of somatic cholesterol do not substantially alter the course of CNS disease in Niemann-Pick C mice [J].
Erickson, RP ;
Garver, WS ;
Camargo, F ;
Hossian, GS ;
Heidenreich, RA .
JOURNAL OF INHERITED METABOLIC DISEASE, 2000, 23 (01) :54-62
[6]   Adult Niemann-Pick disease type C mimicking features of multiple sclerosis [J].
Grau, AJ ;
Brandt, T ;
Weisbrod, M ;
Forsting, M ;
Cantz, M ;
Vanier, MT ;
Harzer, K .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (04) :552-552
[7]   Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone [J].
Griffin, LD ;
Gong, WH ;
Verot, L ;
Mellon, SH .
NATURE MEDICINE, 2004, 10 (07) :704-711
[8]   Niemann-Pick disease type C (a cellular cholesterol lipidosis) treated by bone marrow transplantation [J].
Hsu, YS ;
Hwu, WL ;
Huang, SF ;
Lu, MY ;
Chen, RL ;
Lin, DT ;
Peng, SSF ;
Lin, KH .
BONE MARROW TRANSPLANTATION, 1999, 24 (01) :103-107
[9]   Niemann-Pick disease type C in adults [J].
Imrie, J ;
Vijayaraghaven, S ;
Whitehouse, C ;
Harris, S ;
Heptinstall, L ;
Church, H ;
Cooper, A ;
Besley, GTN ;
Wraith, JE .
JOURNAL OF INHERITED METABOLIC DISEASE, 2002, 25 (06) :491-500
[10]   Identification of novel mutations in the NPC1 gene in German patients with Niemann-Pick C disease [J].
Kaminski, WE ;
Klünemann, HH ;
Ibach, B ;
Aslanidis, C ;
Klein, HE ;
Schmitz, G .
JOURNAL OF INHERITED METABOLIC DISEASE, 2002, 25 (05) :385-389